The impact of platelet function or C-reactive protein, on cardiovascular events after an acute myocardial infarction

Thrombosis Journal

Volumn 7, Issue , 2009, Pages

  Modica, Angelo ^a,b   Karlsson, Fredrik ^a,b   Mooe, Thomas ^a,b  

^a ÖSTERSUND HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOVASCULAR RESPONSE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEATH; FEMALE; FUNCTION TEST; HAZARD RATIO; HEART FAILURE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; ST SEGMENT ELEVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

EID: 68349104184     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-7-12     Document Type: Article

References (35)

1. Cohen M Antman EM Murphy SA Radley D Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes Am Heart J 2002, 143:63-69 10.1067/mhj.2002.119767 11773913
2. Mooe T Eriksson P Stegmayr B Ischemic stroke after acute myocardial infarction. A population-based study Stroke 1997, 28:762-767 9099193
3. Mooe T Olofsson BO Stegmayr B Eriksson P Ischemic stroke. Impact of a recent myocardial infarction Stroke 1999, 30:997-1001 10229734
4. Witt BJ Ballman KV Brown RD Jr Meverden RA Jacobsen SJ Roger VL The incidence of stroke after myocardial infarction: A meta-analysis Am J Med 2006, 119(4):354.e1-354.e9 16564779 10.1016/j.amjmed.2005.10.058
5. Tavazzi L Clinical epidemiology of acute myocardial infarction Am Heart J 1999, 138:S48-54 10.1016/S0002-8703(99)70320-0 10426859
6. Hellermann JP Goraya TY Jacobsen SJ Weston SA Reeder GS Gersh BJ Redfield MM Rodeheffer RJ Yawn BP Roger VL Incidence of heart failure after myocardial infarction: Is it changing over time? Am J Epidemiol 2003, 157:1101-1107 10.1093/aje/kwg078 12796046
7. Jokhadar M Jacobsen SJ Reeder GS Weston SA Roger VL Sudden death and recurrent ischemic events after myocardial infarction in the community Am J Epidemiol 2004, 159:1040-1046 10.1093/aje/kwh147 15155288
8. Guidry UC Evans JC Larson MG Wilson PW Murabito JM Levy D Temporal trends in event rates after Q-wave myocardial infarction: The Framingham Heart Study Circulation 1999, 100:2054-2059 10562260
9. McGovern PG Jacobs DR Jr Shahar E Arnett DK Folsom AR Blackburn H Luepker RV Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: The Minnesota heart survey Circulation 2001, 104:19-24 10.1161/hc3001.093607 11435332
10. Hedlund P Clinical and experimental studies on C-reactive protein (acute phase protein) Acta Med Scand Suppl 1961, 361:1-71 13712705
11. Balbay Y Tikiz H Baptiste RJ Ayaz S Sasmaz H Korkmaz S Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction Angiology 2001, 52:109-114 10.1177/000331970105200204 11228083
12. Brunetti ND Troccoli R Correale M Pellegrino PL Di Biase M C-reactive protein in patients with acute coronary syndrome: Correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings Int J Cardiol 2006, 109:248-256 10.1016/j.ijcard.2005.06.021 16055214
13. Deng P Zhao SP Dai HY Guan XS Huang HG Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response Clin Chem 2006, 52:300-303 10.1373/clinchem.2005.057893 16449211
14. Danesh J Collins R Appleby P Peto R Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies Jama 1998, 279:1477-1482 10.1001/jama.279.18.1477 9600484
15. Lagrand WK Visser CA Hermens WT Niessen HW Verheugt FW Wolbink GJ Hack CE C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 1999, 100:96-102 10393687
16. Morrow DA Rifai N Antman EM Weiner DL McCabe CH Cannon CP Braunwald E C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in Myocardial Infarction J Am Coll Cardiol 1998, 31:1460-1465 10.1016/S0735-1097(98)00136-3 9626820
17. Ridker PM Cushman M Stampfer MJ Tracy RP Hennekens CH Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 1997, 336:973-979 10.1056/NEJM199704033361401 9077376
18. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction Eur Heart J 2000, 21:1502-1513 10.1053/euhj.2000.2305 10973764
19. Kundu SK Heilmann EJ Sio R Garcia C Davidson RM Ostgaard RA Description of an in vitro platelet function analyzer - PFA-100 Semin Thromb Hemost 1995, 21(Suppl 2):106-112 7660150
20. Franchini M The platelet function analyzer (PFA-100): An update on its clinical use Clin Lab 2005, 51:367-372 16122146
21. Cattaneo M Laboratory detection of 'aspirin resistance': What test should we use (if any)? Eur Heart J 2007, 28:1673-1675 10.1093/eurheartj/ ehm232 17586540
22. Ozaki Y Satoh K Yatomi Y Yamamoto T Shirasawa Y Kume S Detection of platelet aggregates with a particle counting method using light scattering Anal Biochem 1994, 218:284-294 10.1006/abio.1994.1180 8074282
23. Satoh K Ozaki Y Qi R Yang L Asazuma N Yatomi Y Kume S Factors that affect the size of platelet aggregates in epinephrine-induced activation: A study using the particle counting method based upon light scattering Thromb Res 1996, 81:515-523 10.1016/0049-3848(96)00026-6 8907310
24. Eto K Takeshita S Ochiai M Ozaki Y Sato T Isshiki T Platelet aggregation in acute coronary syndromes: Use of a new aggregometer with laser light scattering to assess platelet aggregability Cardiovasc Res 1998, 40:223-229 10.1016/S0008-6363(98)00114-X 9876335
25. Sakamoto T Ogawa H Kawano H Hirai N Miyamoto S Takazoe K Soejima H Kugiyama K Yoshimura M Yasue H Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method Thromb Haemost 2000, 83:475-479 10744156
26. Miyamoto S Ogawa H Soejima H Takazoe K Sakamoto T Yoshimura M Kugiyama K Yasue H Formation of platelet aggregates after attacks of coronary spastic angina pectoris Am J Cardiol 2000, 85:494-497 10.1016/ S0002-9149(99)00779-1 10728958
27. Miyamoto S Kawano H Sakamoto T Soejima H Kajiwara I Shimomura H Kojima S Hokamaki J Sugiyama S Hirai N Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease Thromb Haemost 2003, 89:681-686 12669123
28. Ridker PM C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: Moving an inflammatory hypothesis toward consensus J Am Coll Cardiol 2007, 49:2129-2138 10.1016/ j.jacc.2007.02.052 17531663
29. Suleiman M Khatib R Agmon Y Mahamid R Boulos M Kapeliovich M Levy Y Beyar R Markiewicz W Hammerman H Aronson D Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein J Am Coll Cardiol 2006, 47:962-968 10.1016/j.jacc.2005.10.055 16516078
30. Bennermo M Held C Hamsten A Strandberg LE Ericsson CG Hansson LO Tornvall P Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis J Intern Med 2003, 254:244-250 10.1046/ j.1365-2796.2003.01181.x 12930233
31. Chen ZM Jiang LX Chen YP Xie JX Pan HC Peto R Collins R Liu LS Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial Lancet 2005, 366:1607-1621 10.1016/S0140-6736(05)67660-X 16271642
32. Krasopoulos G Brister SJ Beattie WS Buchanan MR Aspirin "resistance" and risk of cardiovascular morbidity: Systematic review and meta-analysis Bmj 2008, 336:195-198 2213873 18202034 10.1136/ bmj.39430.529549.BE
33. Borna C Lazarowski E van Heusden C Ohlin H Erlinge D Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels Thromb J 2005, 3:10 1192820 16045804 10.1186/1477-9560-3-10
34. Hobikoglu GF Norgaz T Aksu H Ozer O Erturk M Nurkalem Z Narin A High frequency of aspirin resistance in patients with acute coronary syndrome Tohoku J Exp Med 2005, 207:59-64 10.1620/tjem.207.59 16082156
35. Gurbel PA Becker RC Mann KG Steinhubl SR Michelson AD Platelet function monitoring in patients with coronary artery disease J Am Coll Cardiol 2007, 50:1822-1834 10.1016/j.jacc.2007.07.051 17980247